Structure-Function Analysis of Vitamin D and VDR Model

Authors: Yamada, S.1; Yamamoto, K.1; Masuno, H.1

Source: Current Pharmaceutical Design, Volume 6, Number 7, May 2000 , pp. 733-748(16)

Publisher: Bentham Science Publishers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

In the first section, the general three-dimensional structure of the ligand-binding domain (LBD) of nuclear receptors (NR) was briefly described on the basis of their x-ray crystal structures. Emphasis was placed on the three major conformations of NR-LBD and their role in the transactivation function. In the second part, the structure-function relationship of vitamin D was analyzed based on the ligand struc-ture, in particular by using systematic conformational analysis as a tool. On the basis of the conformational analysis of the vitamin D side chain and studies using conformationally restricted synthetic vitamin D analogs, we suggested the active space region concept of vitamin D The vitamin D side-chain region was grouped into five regions (A, G, EA, EG and F). Activity orders, in terms of the spatial region, found by these studies are as follows: Affinity for vitamin D receptor (VDR), Affinity for vitamin D binding protein (DBP), Target gene transactivation, Cell differentiation, Bone calcium mobilization, Intestinal calcium absorption, In the third section, homology modeling of VDR-LBD and docking of the natural ligand, 1,25-(OH)2 D 3 , into the ligand binding cavity of the model are described. Amino acid residues forming hydrogen bonds with the biologically important 1alpha - and 25-OH groups were identified: 1alpha-OH forms a pincer-type hydrogen bond with R274 and S237 and 25-OH with H397. This VDR-LBD/1,25-(OH)2 D 3 docking model was firmly substantiated by mutation analysis. Using this VDR model, the structure-function relationship of highly potent vitamin D analogs was discussed.

Keywords: ligand binding domain LBD; nuclear receptors NR; NR LBD; DNA binding domain DBD; Transcriptional Activity; Ligand Docking; Mutational Analysis; Peroxisome proliferator activated receptor; Ligand binding pocket; Transactivation function 2; 4 Hydroxytamoxifen; Genistein; Wild type; Retinoid X receptor; Retinoic acid receptor; Thyroid hormone receptor; Estrogen receptors A and B; Progesterone receptor

Document Type: Research article

Affiliations: 1: Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062, Japan

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A